Hemophilia A: all 885 studies

Page 6 of 9. Open to participants first (139), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate Seroprevalence and Seroconversion of Antibodies to Adeno-Associated Virus (AAV) in Patients With Hemophilia ACompletedNCT04560933
• Sonography and HaemophiliaStatus unknownNCT04550988
• Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding DisordersTerminatedNCT04548791Phase 1/2
• Medication Adherence and Non-adherence in Adults With Rare DiseaseWithdrawnNCT04541875
• Sarcopenia and Osteoporosis in the Patients With HemophiliaCompletedNCT04535180
• Osteoporosis and HaemophiliaStatus unknownNCT04524481
• COVID-19 Quarantine on Musculoskeletal Status in HemophiliaCompletedNCT04491318
• Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or BTerminatedNCT04489537Phase 3
• UPLC-MS/MS Monitoring of Emicizumab TherapyActive, not recruitingNCT04472169
• Study to Learn More About the Safety of Drug Jivi Over a Long Period of Time in Previously Treated Patients With Hemophilia A (Bleeding Disorder Resulting From a Lack of FVIII) Who Are Receiving Jivi Regularly at Their Treating Doctors to Prevent BleedingActive, not recruitingNCT04461639
• An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.CompletedNCT04456387Phase 3
• Evaluation of Static Postural Balance in Children With Hemophilia and Its Relationship With Joint HealthCompletedNCT04406519
• COVID-19 Related Lockdown Effects On Chronic DiseasesCompletedNCT04390126
• Haemophilia and Bone Loss - PHILEOS StudyCompletedNCT04384341Not applicable
• Post-Marketing Surveillance (Use-results Surveillance) With Esperoct®CompletedNCT04334057
• The Effects of Manual Therapy in Hemophilic PatientsCompletedNCT04309903Not applicable
• Effectiveness of Manual Therapy and Strengthening Exercises in Hemophilic Arthropathy of the Elbow JointCompletedNCT04308876Not applicable
• PHYSICAL ACTIVITY AND FVIII CLEARANCE: RELEVANCE FOR PERSONALIZED THERAPY IN SEVERE HAEMOPHILIA A (PHYSEMO)Status unknownNCT04303936Not applicable
• A 48-Month Study to Evaluate Long-Term Effectiveness of Elocta on Joint HealthCompletedNCT04293523
• Medication Exposure in Older Patients With Constitutional Hemorrhagic DiseaseCompletedNCT04282486
• Hemophilia and Bone Metabolism: Study of Monocytic Populations and Inflammatory ProteinsCompletedNCT04206033
• The Effects of Therapeutic Exercises on Kinesiophobia in Haemophilic Patients.CompletedNCT04205188Not applicable
• A Study to Evaluate the Safest Dose Range for FEIBA in Hemophilia A Patients With Inhibitors on EmicizumabActive, not recruitingNCT04205175Phase 4
• Emicizumab in Acquired Hemophilia ACompletedNCT04188639Phase 2
• HemFitBit, an Observational Study of Physical Activity in People With Moderate and Severe Haemophilia ACompletedNCT04181697
• A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia AActive, not recruitingNCT04158934
• Gene Therapy for Chinese Hemophilia BCompletedNCT04135300Not applicable
• Impact on French Physician's Haemophilia Treatment Management Decision Based on Systematic Joint ExaminationCompletedNCT04133883Not applicable
• Handheld Ultrasound (HHUS) for Home Use in HemophiliaCompletedNCT04131920
• Therapeutic Exercise in Patients With HemophiliaTerminatedNCT04114448Not applicable
• The Effectiveness of Recombinant Coagulation Factor IX With Recombinant Albumin (rIX-FP) in Severe Hemophilia B PatientsStatus unknownNCT04108260Phase 4
• A Study of Factor Inhibitors in Adult Patients With Hemophilia and Von Willebrand's Disease in Upper EgyptStatus unknownNCT04106323
• Quality of Life in Hemophilia by Clinical Scoring System (FISH)ScoreStatus unknownNCT04102046
• Study to Learn More About the Physical Activity Level of Patients Suffering From Hemophilia A Treated With Damoctocog Alfa Pegol (LIFE ACTIVE Study)CompletedNCT04091386
• What is the Feasibility of the ISTEP Exercise Test in Boys With HaemophiliaCompletedNCT04076306Not applicable
• The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)CompletedNCT04073498Phase 1/2
• Safety, Efficacy Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.Status unknownNCT04061109Phase 3
• Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.Status unknownNCT04060836Phase 1
• ATHN 11: Liver Transplantation Outcomes StudyCompletedNCT04055051
• Emicizumab PUPs and Nuwiq ITI StudyWithdrawnNCT04030052Phase 3
• Study to Compare How the Body Distributes and Excretes the Drugs Jivi (BAY 94-9027) and Adynovi in Patients With Severe Hemophilia A (Bleeding Disorder Resulting From a Lack of Blood Clotting Factor VIII)CompletedNCT04015492Phase 1
• Study to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe HemophiliaWithdrawnNCT03996486Phase 1
• Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or BCompletedNCT03974113Phase 2/3
• rFVIIIFc (Elocta®) ITI Chart Review in Patients With Haemophilia ACompletedNCT03951103
• Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A.Status unknownNCT03947320Phase 3
• Clinical Trial Comparing a Biosimilar Eptacog Alfa With Novoseven, in Patients With Hemophilia With InhibitorsCompletedNCT03935334Phase 3
• Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia AActive, not recruitingNCT03932201
• Optimizing the Use of Prophylaxis in Patients With Severe Haemophilia ACompletedNCT03915080Phase 4
• Imaging of Arthropathy in Boys With Hemophilia in ChinaCompletedNCT03914716Not applicable
• Extended Half-Life (EHL) Clotting Factor for Improving the Musculoskeletal Health of Patients With HemophiliaStatus unknownNCT03914209
• Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A ParticipantsCompletedNCT03876301
• A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia PatientsCompletedNCT03855696Phase 1
• Efficacy of Strength Training in Improving Elbow Range of Motion and Function in Adults With HemophiliaCompletedNCT03842605Not applicable
• Characterizing the Impact and Treatment of Reproductive Tract Bleeding on Women and Post-menarchal Girls With Bleeding DisordersCompletedNCT03834727
• Post Marketing Surveillance Study for ADYNOVATE in South KoreaCompletedNCT03824522
• Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia AActive, not recruitingNCT03818763Phase 1
• ATHN 8: Previously Untreated Patients (PUPs) Matter StudyCompletedNCT03818529
• Evaluation of SCT800 in Prophylaxis Therapy on Previous Treated Patients With Severe Hemophilia ACompletedNCT03815318Phase 3
• Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IXCompletedNCT03754790Phase 3
• A Study to Evaluate the Pharmacokinetics of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for InjectionStatus unknownNCT03747653
• A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)CompletedNCT03741881
• Study to Evaluate Rituximab and Bortezomib in Patients With Newly Diagnosed Acquired Hemophilia AStatus unknownNCT03700229Phase 2
• A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With HemophiliaCompletedNCT03660774
• A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in FranceCompletedNCT03655340
• Early Check: Expanded Screening in NewbornsActive, not recruitingNCT03655223
• A Long-Term Follow-Up Study of Haemophilia B Patients Who Have Undergone Gene TherapyTerminatedNCT03641703Phase 1/2
• The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and BCompletedNCT03623295
• Pharmacokinetic (PK)Research on Chinese Children of HemophiliaStatus unknownNCT03622476Phase 4
• ATHN 7: Hemophilia Natural History StudyCompletedNCT03619863
• Personalized Medicine for Canadians With HemophiliaStatus unknownNCT03615053Not applicable
• Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing RegistryTerminatedNCT03603275
• Low-dose ITI Strategy for Children in Hemophilia A With High-titer Inhibitor and Poor ITI Risk in ChinaStatus unknownNCT03598725Phase 4
• MOTHIF II : THERAPEUTIC MANAGEMENT AND USE OF CLOTTING FACTORS IN HEMOPHILIA A & B IN FRANCE IICompletedNCT03596814
• Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle"CompletedNCT03588299Phase 1/2
• The Effects of Core Stabilization Exercises in Addition to Balance Exercises in Adult Hemophilia Patients on Balance, Quality of Life, Lower Limb Muscle Strength and Functional LevelCompletedNCT03574922Not applicable
• Gait Examination in Patients With Hemophilia in AustriaCompletedNCT03541811
• Web Accessible Population Pharmacokinetics Service - Hemophilia: Sources of VariabilityStatus unknownNCT03533504
• Psychology and Physiotherapy Approach of Chronic Pain in Patients With HemophiliaCompletedNCT03529474Not applicable
• Virtual Reality for HemophiliaCompletedNCT03507582Not applicable
• PET Imaging of Hemophilic ArthropathyCompletedNCT03485170Not applicable
• A Study to Assess Pharmacokinetics and Pharmacodynamics Following Administration of BAY1093884 in Patients With Severe HemophiliaCompletedNCT03481946Phase 1
• Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia AActive, not recruitingNCT03432520
• Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)CompletedNCT03430154
• Evaluation of Patient and Physician Reported Reasons for Switching Factor VIII Replacement TherapiesCompletedNCT03405337
• Exercise Versus DDAVP in Patients With Mild Hemophilia ACompletedNCT03379974Phase 4
• Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSevenCompletedNCT03372993
• BAY94-9027 PK Study Comparing to Another Long Acting ProductCompletedNCT03364998Phase 1
• Health Practice of Hemophilia Patiente Care During Pregnancy, Delivery and Newborn ChildrenCompletedNCT03360149
• Joint Health StudyCompletedNCT03358836
• Evaluation of a Standardized Protocol for Thrombin Generation AssayCompletedNCT03313531
• Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia BTerminatedNCT03307980Phase 2
• Occupational Integration of Adults With Severe Haemophilia in France: a Study Based on the FranceCoag CohortCompletedNCT03301376
• Quality of Life and Adjustment Among Siblings of Children and Adolescents With Severe HemophiliaCompletedNCT03299699
• Inter Individual Variability in Initiation Pathway Activation and Regulation and Phenotypic Heterogeneity in Patients With Haemophilia A and BStatus unknownNCT03287999
• Comparison of Ideal vs. Actual Weight Base Factor DosingStatus unknownNCT03286153Not applicable
• Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and BCompletedNCT03276130
• Extended Half Life Factor (EHF) Products For Heavy Menstrual Bleeding in Hemophilia CarriersCompletedNCT03272568Early Phase 1
• Combining Registry Data in Haemophilia: TARGET HCompletedNCT03264014
• HEAD-US SCORING SYSTEM: Assessment of the Real-world Impact of UltrasoundStatus unknownNCT03237273Not applicable
• Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life PracticeCompletedNCT03199794

← Hemophilia A overview